"......and the funds from the zenith sale will more then meet the financial requirement of listing, coming back to Resverlogix through ZCC"

Coldnewfie, could you explain your hypothetical scenario in more detail? As I'm sure you know, Zenith Epigenetics Ltd (ZEL) is a wholly-owned subsidiary of Zenith Capital Corp. (ZCC), and ZCC holds the royalty preferred shares of Resverlogix. Are you assuming that just ZEL is sold? What obligation at all does ZCC have to move money into Resverlogix? How would this work? Private placement? Something else? 

Thanks,

BearDownAZ